Clarametyx Biosciences Announces Positive Topline Data From Phase 2a Study Evaluating CMTX-101 in Cystic Fibrosis

Clarametyx today announced positive topline data from a Phase 1b/2a trial evaluating its novel antibody therapy, CMTX-101, in cystic fibrosis (CF).
Verywell Health on MSN

6 Fruits That Can Help You Feel Better When You’re Sick

Fruits to eat when sick include hydrating fruits like watermelon. Eat citrus fruits and berries because they are rich in ...

Krystal Biotech, Inc.: Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespect ...
Onmanorama

Holding your breath from point A to B: Is it a sign of healthy lungs?

While there is no general consensus on this, the Ohio State University estimates the safe limit for holding your breath at 1 ...

Improving sleep isn't enough: Daytime function as a key to assessing insomnia treatments

About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and ...

Control valve discovered in gut's plumbing system may hold answers to constipation and diarrhea

Although constipation and diarrhea may seem like opposite problems, they both hinge on the same underlying issue: how much fluid moves into the gut. These common issues affect millions of people in ...